These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20699113)

  • 1. A novel dry powder inhaler: Effect of device design on dispersion performance.
    Selvam P; McNair D; Truman R; Smyth HD
    Int J Pharm; 2010 Nov; 401(1-2):1-6. PubMed ID: 20699113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
    Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
    Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dry powder inhaler with reduced mouth-throat deposition.
    Wang ZL; Grgic B; Finlay WH
    J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
    J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.
    Leung CMS; Tong Z; Zhou QT; Chan JGY; Tang P; Sun S; Yang R; Chan HK
    AAPS J; 2016 Sep; 18(5):1159-1167. PubMed ID: 27161214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model.
    Sinha B; Mukherjee B
    Drug Dev Ind Pharm; 2012 Feb; 38(2):171-9. PubMed ID: 21721851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry powder inhaler formulation.
    Telko MJ; Hickey AJ
    Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs.
    Martinelli F; Balducci AG; Rossi A; Sonvico F; Colombo P; Buttini F
    Int J Pharm; 2015 Jun; 487(1-2):197-204. PubMed ID: 25843756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of a dry powder inhaler: device design and optimisation.
    Friebel C; Steckel H; Müller BW
    J Pharm Pharmacol; 2012 Sep; 64(9):1303-15. PubMed ID: 22881442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.
    Longest W; Farkas D
    AAPS J; 2019 Feb; 21(2):25. PubMed ID: 30734133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for the aerodynamic design of dry powder inhalers.
    Ertunç O; Köksoy C; Wachtel H; Delgado A
    Int J Pharm; 2011 Sep; 416(1):25-34. PubMed ID: 21718768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the mouthpiece and chamber of Turbuhaler® on the aerosolization of API-only powder formulations.
    Zhu Q; Gou D; Chan HK; Kourmatzis A; Yang R
    Int J Pharm; 2023 Apr; 637():122871. PubMed ID: 36948474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Texture and Surface Chemistry on Deagglomeration and Powder Retention in Capsule-Based Dry Powder Inhaler.
    Groß R; Berkenfeld K; Schulte C; Ebert A; Sule S; Sule A; Lamprecht A
    AAPS PharmSciTech; 2022 Oct; 23(7):281. PubMed ID: 36241775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhalers (DPIs)--a review of device reliability and innovation.
    Islam N; Gladki E
    Int J Pharm; 2008 Aug; 360(1-2):1-11. PubMed ID: 18583072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of powder residence time for the aerosol delivery performance of a commercial dry powder inhaler Aerolizer(®).
    Jiang L; Tang Y; Zhang H; Lu X; Chen X; Zhu J
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):265-79. PubMed ID: 22280548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inflow conditioning for dry powder inhalers.
    Singh G; Lowe A; Azeem A; Cheng S; Chan HK; Walenga R; Kourmatzis A
    Int J Pharm; 2021 Oct; 608():121085. PubMed ID: 34508843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the Entrainment Geometry of a Dry Powder Inhaler: Methodology and Preliminary Results.
    Kopsch T; Murnane D; Symons D
    Pharm Res; 2016 Nov; 33(11):2668-79. PubMed ID: 27401410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.